CasNo.604769-01-9,R306465,5-Pyrimidinecarboxamide, N-hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]- (9CI)(604769-01-9) Suppliers

0	Negotiable

Min.Order :0
Purity: 95%

Keywords

R 306465 R-306465

Quick Details

Appearance:
Application:Histone Deacetylase Inhibitors
PackAge:
ProductionCapacity:
Storage:
Transportation:

Superiority:

We provide customized and high-quality R306465 product for your project.

Details:

R306465, also known as JNJ-16241199, is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models. R306465 was found to be a potent inhibitor of HDAC1 and -8 (class I) in vitro. R306465 potently inhibited cell proliferation of all main solid tumour indications, including ovarian, lung, colon, breast and prostate cancer cell lines, with IC50 values ranging from 30 to 300 nM. The high activity of R306465 in cell-based assays and in vivo after oral administration makes R306465 a promising novel antitumoral agent with potential applicability in a broad spectrum of human malignancies.